Immediate Impact
7 from Science/Nature 59 standout
Citing Papers
The KEYNOTE-811 trial of dual PD-1 and HER2 blockade in HER2-positive gastric cancer
2021 StandoutNature
The changing landscape of atherosclerosis
2021 StandoutNature
Works of Uma Kher being referenced
Efficacy of pembrolizumab (pembro) monotherapy versus chemotherapy for PD-L1–positive (CPS ≥10) advanced G/GEJ cancer in the phase II KEYNOTE-059 (cohort 1) and phase III KEYNOTE-061 and KEYNOTE-062 studies.
2020
Reduction in Total Cardiovascular Events With Ezetimibe/Simvastatin Post-Acute Coronary Syndrome
2016
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Uma Kher | 882 | 599 | 546 | 36 | 2.0k | |
| Sri Harsha Tella | 936 | 636 | 399 | 95 | 2.4k | |
| Albrecht Guhlmann | 511 | 612 | 1310 | 38 | 3.1k | |
| Azeez Farooki | 1445 | 566 | 371 | 60 | 2.6k | |
| Sverre Harvei | 396 | 182 | 411 | 26 | 1.4k | |
| Michela Donadio | 1073 | 247 | 323 | 66 | 1.8k | |
| Herman Nilsson‐Ehle | 650 | 158 | 159 | 58 | 2.0k | |
| John Sibley | 229 | 294 | 215 | 37 | 2.7k | |
| Takami Miki | 352 | 308 | 263 | 54 | 2.3k | |
| Svante Jansson | 539 | 1043 | 140 | 59 | 2.3k | |
| Erhard Hiller | 303 | 325 | 236 | 83 | 2.0k |
All Works
Loading papers...